Top Story

Canagliflozin-metformin combo drug added benefits unproven, German quality group says

November 24, 2014

The new fixed combination of canagliflozin with metformin to treat type 2 diabetes offers no added benefit over the appropriate comparator therapy, according to a press release from the German Institute for Quality and Efficiency in Health Care.

A dossier assessment for the drug, approved since April 2014 for use in adult patients unable to achieve adequate glycemic control through diet and exercise alone, did not present data for possible subindications, the group argued.

In the Journals

Economic burden of diabetes continues to grow

November 24, 2014
Recent study findings published in Diabetes Care suggest that the economic burden of diabetes in the United States is continuing to rise. “These statistics…
NAFLD associated with high BP, hypertension in children In the Journals

NAFLD associated with high BP, hypertension in children

November 24, 2014
Pediatric patients with nonalcoholic fatty liver disease were more likely to have high blood pressure and persistent high blood pressure compared with children without…
In the Journals

Negative weight perception may limit weight loss outcomes in patients with bariatric surgery

November 24, 2014
In patients undergoing weight loss surgery, greater preoperative internalized weight bias is related to most postoperative depressive symptoms and a lower percentage of…
In the Journals

HbA1c, diabetic retinopathy relationship supports cut-point diagnosis in Asians

November 24, 2014
The use of HbA1c levels to diagnose diabetes is appropriate among Asian populations, according to research published in The Journal of Clinical Endocrinology &
More News Headlines »
CME
Screening and Treatment of Diabetes-Associated Eye Disease

Screening and Treatment of Diabetes-Associated Eye Disease: Out of Sight, Out of Mind?

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy is a major cause of blindness among adults aged 40 years and older. Optimal outcomes necessitates…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
CME
Acromegaly Cases

Acromegaly Cases: Expert Insights into Diagnosis and Emerging Treatment Options – Part 5 of 5

This activity is supported by an educational grant from Genentech.

Acromegaly is a rare chronic disorder that is typically caused by excessive growth hormone secretion, and is…
More »
morganatic-roan
morganatic-roan